Generated by GPT-5-mini| Duke Eye Center | |
|---|---|
| Name | Duke Eye Center |
| Location | Durham, North Carolina |
| Country | United States |
| Affiliation | Duke University School of Medicine |
| Founded | 1953 |
Duke Eye Center is the ophthalmology department of Duke University School of Medicine located in Durham, North Carolina. It provides subspecialty care in cornea, retina, glaucoma, pediatric ophthalmology, neuro-ophthalmology and oculoplastics while integrating clinical trials and basic science research. The center collaborates with institutions such as Johns Hopkins Hospital, Massachusetts General Hospital, Mayo Clinic, Wilmer Eye Institute and industry partners to advance therapies for retinal disease, corneal disorders, glaucoma, and ocular oncology.
The ophthalmology program began as part of Duke University's expansion of clinical departments in the mid-20th century, formalized during the 1950s under leaders recruited from institutions like Harvard Medical School and Johns Hopkins University. Early milestones included establishing residency training recognized by the American Board of Ophthalmology and launching fellowship programs patterned after those at Wills Eye Hospital and Bascom Palmer Eye Institute. Over the decades the center expanded its scope through collaborations with the National Eye Institute, participation in multicenter trials coordinated by the American Academy of Ophthalmology and contributions to standards promulgated by the World Health Organization's vision initiatives. Growth reflected broader trends in ophthalmic subspecialization influenced by pioneers linked to University of California, San Francisco, Columbia University Irving Medical Center, and University of Michigan.
Primary clinical and research activities are anchored on the Duke University Hospital campus in Durham, North Carolina, with satellite clinics serving the Research Triangle Park region and referral centers across North Carolina and neighboring states. Facilities include ambulatory surgery suites equipped for phacoemulsification and vitrectomy comparable to those at Cleveland Clinic and dedicated clinical trial units modeled on protocols used at NIH Clinical Center. The center houses imaging cores with adaptive optics and optical coherence tomography systems similar to platforms at Stanford University School of Medicine and shares translational laboratories with the Duke Human Vaccine Institute, the Duke Cancer Institute and the Duke Global Health Institute for cross-disciplinary projects. Outreach programs operate in partnership with Blue Cross and Blue Shield of North Carolina initiatives and regional health systems such as UNC Health and WakeMed Health.
Clinical specialties include corneal transplantation and keratoprosthesis services informed by techniques from Bascom Palmer Eye Institute, retinal surgery and intravitreal pharmacotherapy paralleling protocols from Vitreous Retina Consultants, glaucoma surgery including trabeculectomy and MIGS influenced by studies from Moorfields Eye Hospital, pediatric ophthalmology and strabismus care modeled after programs at Children's Hospital of Philadelphia, ocular oncology managing uveal melanoma and retinoblastoma with approaches akin to those at Memorial Sloan Kettering Cancer Center, and neuro-ophthalmology referencing work from Massachusetts Eye and Ear. Subspecialty clinics provide diagnostics using equipment and protocols common to American Society of Retina Specialists members and perform genetic testing in collaboration with labs affiliated with Broad Institute and Johns Hopkins Kimmel Cancer Center.
Research programs span basic, translational and clinical domains, including gene therapy studies influenced by seminal trials at University College London and vector development comparable to projects at University of Pennsylvania. Ongoing clinical trials follow regulatory frameworks established by the U.S. Food and Drug Administration and consortia such as the All of Us Research Program. Investigations target age-related macular degeneration, diabetic retinopathy, inherited retinal dystrophies, corneal endothelial disease and glaucoma biology, often in concert with the Duke Translational Medicine Institute and collaborators at National Institutes of Health. Educational activities include residency accredited by the Accreditation Council for Graduate Medical Education, fellowships modeled after programs at Wills Eye Hospital and curricular integration with the Duke-NUS Medical School exchange programs. Faculty publish in journals such as Ophthalmology (journal), Investigative Ophthalmology & Visual Science, and JAMA Ophthalmology and present at meetings of the Association for Research in Vision and Ophthalmology and the American Academy of Ophthalmology.
Leadership has included chairs and division chiefs who trained at Harvard Medical School, Johns Hopkins University School of Medicine, Mayo Clinic Alix School of Medicine and University of California, San Francisco School of Medicine. Notable clinicians and investigators have collaborated with leaders from Bascom Palmer Eye Institute, Wilmer Eye Institute, and Moorfields Eye Hospital on multicenter trials. Visiting professors and endowed chairholders have included faculty connected to Massachusetts General Hospital, Stanford University School of Medicine, and Columbia University. Administrative and clinical leaders have served on advisory panels for the National Eye Institute and the American Board of Ophthalmology.
The center has been cited in rankings by publications and organizations that evaluate clinical outcomes and research productivity, alongside institutions like Mayo Clinic, Cleveland Clinic and Johns Hopkins Hospital. Faculty have received awards from the Association for Research in Vision and Ophthalmology, the American Academy of Ophthalmology and honors from state medical societies such as the North Carolina Medical Society. Research grants have been awarded by the National Institutes of Health, including the National Eye Institute, and philanthropic support has come from foundations similar to the Lasker Foundation and regional benefactors.